semaglutide vomiting bile Resmetirom and in metabolic dysfunction-associated steatohepatitis (MASH): a comparative perspective Throwing Up on a GLP-1:

The liver is a central immunological organ with a high exposure to circulating pathogens and endotoxin from the gut microbiota

Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro

Personalized Risk Assessment and Genetic Context for IBD Patients Genetic factors influence both Crohn's disease severity and individual response to metabolic medications

285 Immune cells infiltrate peripheral nerves in diabetes patients, releasing additional inflammatory mediators that exacerbate nerve injury

Vildagliptin has been approved for use by the European Medicines Agency (EMA), but has not been approved for use in the US by the US FDA